Navigation Links
Epichem and AR Brown Sign Exclusive Distribution Agreement for Japan, Taiwan, China and South Korea
Date:5/16/2011

PERTH, Australia, May 17, 2011 /PRNewswire/ -- Australian supplier of API analytical standards Epichem, announced today it has signed an exclusive distributor agreement with a leading Japanese Life Sciences supplier company, AR Brown, for sales to Japan, Taiwan, China and South Korea.

Headquartered in Tokyo, AR Brown is one of Japan's largest distributors in the chemical, pharmaceutical and biotechnology industries and have earned the reputation as a strong and reliable supplier. They manage a large and sophisticated network of supplier partnerships in several countries.  The strong business relationships established over 50 years allow AR Brown to provide technical knowledge and information needed to their large customer base to actively sell Epichem's API analytical standards primarily to support the various needs of companies manufacturing over-the-counter and generic medicines.  

Dr Wayne Best, Managing Director of Epichem commented, "Epichem is globally competitive with clients in over 20 countries and is rapidly expanding its reach.  I am very proud that Epichem has joined forces with AR Brown to open these new markets.  AR Brown has a long and successful trading history and is highly respected in the region.  It is satisfying to find a distributor whose motto is "Think Quality".  This motto emulates the culture at Epichem and prevails right through our range of products and services.  AR Brown is exactly the kind of distributor we were looking for in this region.  We are currently seeking distribution in Europe, South America, the United States and Canada."

About Epichem

Epichem is a wholly owned subsidiary of the ASX listed company PharmAust Limited.  Located in Perth, Australia, Epichem has been delivering synthetic and medicinal chemistry services to the drug discovery and pharmaceutical industries for more than 7 years.  Epichem offers a range of rare and hard to find pharmaceutical impurities, degradants and metabolites of active ingredients and excipients, particularly for OTC and generic drugs.  Epichem has been at the forefront of synthesizing new and difficult to obtain standards and many of these are exclusive to Epichem and not available elsewhere.  This range is continually expanding in response to customer requests and developments in the industry.  The company has a robust Quality System in place and all batches of standards are fully traceable.  Epichem's laboratory and systems have passed audits by four of the world's top pharmaceutical companies and all standards are supplied with a Certificate of Analysis and MSDS.  These standards can be supplied in multigram quantities which is ideal for companies undertaking rapid and cost effect stability testing for product development.  Epichem maintains stocks of its standards and can thus be shipped to customers immediately.  Epichem also excels in custom synthesis and contract drug discovery, boasting a highly skilled team of scientists, most with a PhD and industry experience.   This valuable investment in people allows Epichem to lead drug discovery programs, perform custom synthesis, conduct optimisation and method development for scale-up and engage in high-level problem solving.  

Epichem Pty Ltd, Murdoch University Campus,
South Street, Murdoch WA 6150, Australia
Tel  + 61 (0)8 9360 7696
Fax  + 61 (0)8 9360 7699
www.epichem.com.au
ABN 80 106 769 902

For more information:
Barry Epstein
Vice President Marketing
Telephone +61 (0)8 9360 7696
Mobile/Cell + 61 (0)488 236 600
Email barry.epstein@epichem.com.au
Website www.epichem.com.au

Toshinori Fujiwara
Product Manager, Life Sciences
Telephone +81 6 6282 4004
Mobile/Cell  +81 (90) 2164-3121
Email fujiwara@arbrown.com
Website www.arbrown.com


'/>"/>
SOURCE Epichem Pty Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Brown chemists report promising advance in fuel-cell technology
2. Brown University scientists discover new principle in material science
3. Silicon Kinetics Announces Addition of Dr. Rick Brown and Dr. Eric Topol to Its Board of Directors
4. Brown physicist discovers odd, fluctuating magnetic waves
5. Veteran Intellectual Property Team Joins Brown Rudnick
6. Brown engineering professor wins prestigious White House award
7. Marriott Resort Magically Turns Brown Grease "Green" With The Cost-Cutting Hydrologix GRS
8. TechConnect World Conference Showcases Houston Leaders May 3-7, at the George R. Brown Convention Center
9. TechConnect World Announces The CancerNano 2009 Symposium May 3-7, at the George R. Brown Convention Center in Houston
10. Brown chemists create more efficient palladium fuel cell catalysts
11. Jennifer Brownstein, of CONNEXION Healthcare, Honored as Rising Star by Healthcare Businesswomens Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Dec. 8, 2016  Renova™ Therapeutics, a biotechnology ... failure and type 2 diabetes, announced that it ... adeno-associated virus (AAV) vector developed in the laboratory ... at Stanford University. The company plans to use ... therapy product pipeline. "Early research ...
(Date:12/8/2016)... Oxford Gene Technology (OGT), ... panel range with the launch of the SureSeq myPanel™ NGS ... variants in familial hypercholesterolemia (FH). The panel delivers single nucleotide ... single small panel and allows customisation by ,mix and match, ... for LDLR , P C SK9 ...
(Date:12/8/2016)... ... December 08, 2016 , ... This CAST literature review and report looks at ... focus on the economic effects in countries that are major global commodity exporters and ... the resultant risk of low level presence (LLP) puts large volumes of trade worth ...
(Date:12/8/2016)... 8, 2016 Eutilex Co. Ltd. today announced ... $18.9M) Series A financing. This financing round included participation ... and SNU Bio Angel. This new funding brings the ... (US $27.7M) since its founding in 2015. ... development and commercialization of its immuno-oncology programs, expand its ...
Breaking Biology Technology:
(Date:12/5/2016)... , Dec. 5, 2016  The Office ... today published "Can CT Scans Enhance or Replace ... the potential of supporting or replacing forensic autopsies ... CT scan. In response to recommendations ... is exploring using CT scans as a potential ...
(Date:12/2/2016)... , Dec. 1, 2016   SoftServe , ... BioLock , an electrocardiogram (ECG) biosensor analysis ... a key IoT asset. The smart system ensures ... vehicle,s steering wheel and mobile devices to easily ... As vehicle technology advances, so too ...
(Date:11/30/2016)... , Nov. 30, 2016  higi SH ... new partnership initiative targeting national brands, industry thought-leaders ... reward their respective audiences for taking steps to ... its inception in 2012, higi has built the ... impacting over 38 million people who have conducted ...
Breaking Biology News(10 mins):